Percutaneous sensitization with allergens through barrier-disrupted skin elicits a Th2-dominant cytokine response

European Journal of Immunology

Volumn 28, Issue 3, 1998, Pages 769-779

  Kondo, Hidehiko ^a   Ichikawa, Yoshiaki ^a   Imokawa, Genji ^a  

^a KAO CORPORATION   (Japan)

Author keywords

Allergy; Barrier function; House dust mite antigen; Th1 Th2

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATOPIC DERMATITIS; FEMALE; HELPER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN SENSITIZATION;

ALLERGENS; ANIMALS; DERMATITIS, CONTACT; EOSINOPHILS; FEMALE; IMMUNOGLOBULINS; INTERFERON TYPE II; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; LYMPH NODES; MICE; MICE, INBRED BALB C; MITES; PERMEABILITY; PICRYL CHLORIDE; RNA, MESSENGER; SKIN; TH2 CELLS; TIME FACTORS;

EID: 0031881256     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H     Document Type: Article

References (49)

1. Imokawa, G., Abe, A., Gin, K., Higaki, Y., Kawashima, M. and Hidano, A., Decreased level of ceramides in stratum corneum of atopic dermatitis: An etiologic factor in atopic dry skin? J. Invest. Dermatol. 1991. 96: 523-526.
2. Wierenga, E. A., Snoek, M., Bos, J. D., Jansen, H. M. and Kapsenberg, M. L., Comparison of diversity and function of house dust mite-specific T lymphocyte clones from atopic and non-atopic donors. Eur. J. Immunol. 1990. 20: 1519-1526.
3. + Allergen-specific T Lymphocytes in Atopic Dermatitis Lesional Skin. J. Invest. Dermatol. 1991. 97: 389-394.
4. Ogawa, M., Berger, P. A., McGerity, J. L. and Lewis, C. W., Atopic disease and serum immunoglobulin E. Arch. Dermatol. 1971. 103: 575-580.
5. Gurevitch, A. W., Heiner, D. C. and Reisner, R. M., IgE in atopic dermatitis and other common dermatoses. Arch. Dermatol. 1973. 107: 712-715.
6. Jones, H. E., Inouye, J. C., McGerity, J. L. and Lewis, C. W., Atopic disease and serum immunoglobulin E. Br. J. Dermatol. 1975. 92: 17-25.
7. Jabara, H. H., Fu, V., Geha, R. S. and Vercelli, D., CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 1990. 172: 1861-1864.
8. Clutterbuck, E., Shields, J. G., Gordon, J., Smith, S. H., Boyd, A., Callard, R. E., Campbell, H. D., Young, I. G. and Sanderson, C. J., Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays. Eur. J. Immunol. 1987. 17: 1743-1750.
9. Lopez, A. F., Sanderson, C. J., Gamble, J. R., Campbell, H. D., Young, I. G. and Vadas, M. A., Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 1988. 167: 219-224.
10. Imokawa, G. Yada, Y., Higuchi, K., Okuda, M., Ohashi, Y. and Kawamata, A., Pseudo-acylceramide with linoleic acid produces selective recovery of diminished cutaneous barrier function in essential fatty acid deficient rats and has an inhibitory effect on epidermal hyperplasia. J. Clin. Invest. 1994. 94: 89-96.
11. Umeda, Y., Mizutani, H., Yamamoto, K., Imokawa, G. and Shimizu, M., Successful protection of antigen specific dermatitic reaction in atopic dermatitis by topical O-acylceramides (abstr). J. Invest. Dermatol. 1993. 101: 419.
12. Mohler, K. M. and Butler, L. D., Differential production of IL-2 and IL-4 mRNA in vivo after primary sensitization. J. Immunol. 1990. 145: 1734-1739.
13. Lee, F., Yokota, T., Otsuka, T., Meyerson, P., Villaret, D., Coffman, R., Mosmann, T., Rennick, D., Roehm, N., Smith, C., Zlotnik, A. and Arai, K., Isolation and characterization of a mouse interleukin cDNA clone that expresses B-cell stimulatory factor 1 activities and T-cell-and mast-cell-stimulating activities. Proc. Natl. Acad. Sci. USA 1986. 83: 2061-2065.
14. Vitetta, E. S., Ohara, J., Myers, C. D., Layton, J. E., Krammer, P. H. and Paul, W. E., Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. J. Exp. Med. 1985. 162: 1726-1731.
15. Snapper, C. M. and Paul, W. E., Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 1987. 236: 944-947.
16. Oka, D., Nakagawa, S. and Ueki, H., The suppressive effect of tape-stripping treatment of guinea-pig skin on the induction of contact sensitivity by intradermal injection of haptenated epidermal cells. Arch. Dermatol, Res. 1985. 278: 102-1067.
17. Leiferman, K. M., Ackerman, S. J., Sampson, H. A., Cenencie, P. Y. and Gleich, G. J., Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N. Engl. J. Med. 1985. 313: 282-285.
18. Yamada, N., Wakugawa, M., Kuwata, S., Nakagawa, H. and Tamaki, K., Changes in eosinophil and leukocyte infiltration and expression of IL-6 and IL-7 messenger RNA in mite allergen patch test reactions in atopic dermatitis. J. Allergy Clin. Immunol. 1996. 98: 201-206.
19. Judo, K., Renz, H., Abe, J., Gelfand, E. W. and Leung, D. Y., Decreased Interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis. J. Allergy Clin. Immunol. 1992. 90: 323-331.
20. Reinhold, U., Wehrmann, W., Kukel, S. and Kreysel, H. W., Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities. Clin. Exp. Immunol. 1990. 79: 374-379.
21. Bruijnzeel-Koomen, C. A. F. M., van Wichen, D. F., Spry, C. J. F., Venge, P. and Bruijnzeel, P. L. B., Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis. Br. J. Dermatol. 1988. 118: 229-238.
22. Leiferman, K. M., Ackerman, S. J., Sampson, H. A., Haugen, H. S., Venencie, P. Y. and Gleich, G. J., Dermal depositions of eosinophil-granule major basic protein in atopic dermatitis. N. Engl. J. Med. 1985. 313: 282-285.
23. Cheng, J., Ott, N., Peterson, E., George, T., Gleich, G. J. and Leiferman, K. M., Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration (abstr). J. Invest. Dermatol. 1993. 100: 545.
24. Yamada, N., Wakugawa, M., Kuwata, S., Yoshida, T. and Nakagawa, H., Chronologic analysis of in situ cytokine expression in mite allergen-induced dermatitis in atopic subjects. J. Allergy Clin. Immunol. 1995. 96: 1069-1075.
25. Chapman, M. D. and Platts-Mills, T. A. E., Purification and characterization of the major allergen P1. J. Immunol. 1980. 125: 587-592.
26. Lind, P., Purification and partial characterization of two major allergens from the house dust Dermatophagoides pteronyssinus. J. Allergy Clin. Immunol. 1985. 76: 753-761.
27. Holck, A., Dale, S. and Sletten, K., Purification and characterization of a major allergen from the house dust mite Dermatophagoides farinae. Allergy 1986. 41: 408-417.
28. Maeda, K., Yamamoto, K., Tanaka, Y., Anan, S. and Yoshida, H., House dust mite (HDM) antigen in naturally occurring lesions of atopic dermatitis (AD): the relationship between HDM antigen in the skin and HDM antigenspecific IgE antibody. J. Dermatol. Sci. 1992. 3: 73-77.
29. Stafford, A. N., Rider, S. H., Hopkin, J. M., Cookson, W. O. and Monaco, A. P., A 2.8 Mb YAC contig in 11q12-q13 localizes candidate genes for atopy: FcεRI beta and CD20. Hum. Mol. Genet. 1994. 3: 779-785.
30. Shirakawa, T., Li, A., Dubowitz, M., Dekker, J. M., Shaw, A. E., Faux, J. A., Ra, C., Cookson, W. O. and Hopkin, J. M., Association between atopy and variants of the β subunit of the high-affinity immunoglobulin E receptor. Nat. Genet. 1994. 7: 125-129.
31. Takafuji, S., Suzuki, S., Muranaka, M. and Miyamoto, T., Influence of environmental factors on IgE production. Ciba Found. Symp. 1989. 147: 188-201.
32. Tepper, R. I., Levinson, D. A., Stanger, B. Z., Campos-Torres, J., Abbas, A. K. and Leder, P., IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice. Cell 1990. 62: 457-467.
33. Tepper, R. I., Coffman, R. L. and Leder, P., An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 1992. 257: 548-551.
34. Müler, K. M., Jaunin, F., Masouyé, I., Saurat, J.-H. and Hause, C., Th2 cells mediate IL-4-dependent local tissue inflammation. J. Immunol. 1993. 150: 5576-5584.
35. Müler, K. M., Jaunin, F., Masouyé, I., Piguet, P.-F., Saurat, J.-H. and Hause, C., Involvement of granulocytes and the adhesion receptors intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in tissue inflammation induced by Th2-type helpte cells. J. Invest. Dermatol. 1995. 104: 350-354.
36. Nickoloff, B. J. and Naidu, Y., Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J. Am. Acad. Dermatol. 1993. 30: 535-546.
37. Nickoloff, B. J., Fivenson, D. P., Kunkel, S. L., Strieter, R. M. and Turka, L. A., Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary snydrome, but not in psoriatic plaques. Clin. Immunol. Immunophathol. 1994. 73: 63-68.
38. Ullich, S. E., Mechanism involved in the systemic suppression of antigen-presenting cell function by UV Irradiation: Keratinocyte-derived IL-10 modulates antigen-presenting cell function of splenic adherent cells. J. Immunol. 1994. 152: 3410-3416.
39. Hino, A. and Nariuchi, H., Negative feedback mechanism suppresses interleukin-12 production by antigen-presenting cells interacting with T helper 2 cells. Eur. J. Immunol. 1996. 26: 623-628.
40. Ozawa, H., Aiba, S., Nakawaga, S. and Tagami, H., Interferon-γ and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression. Eur. J. Immunol. 1996. 26: 648-652.
41. Grubauer, G., Elias, G. P. M. and Feingold, K. R., Transepidermal waterloss: the signal for recovery of barrier structure and function. J. Lipid Res. 1989. 30: 323-334.
42. Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987. 162: 156-159.
43. Yokota, T., Arai, N., Lee, F., Rennick, D., Mosmann, T. and Aarai, K., Use of cDNA expression vector for isolation of mouse interleukin 2 cDNA clones: Expression of T-cell growth-factor activity after transfection of monkey cells. Proc. Natl. Acad. Sci. USA 1985. 82: 68-72.
44. Grenett, H. E., Fuentes, N. L. and Fuller G. M., Cloning and sequence analysis of the cDNA for murine interleukin-6. Nucleic Acids Res. 1990. 18: 6455.
45. Gray, P. W. and Goeddel, D. V., Cloning and expression of murine immune interferon cDNA. Proc. Natl. Acad. Sci. USA 1983. 80: 5842-5846.
46. Ishida, N., Ueda, S., Hayashida, H., Miyata, T. and Honjo, T., The nucleotide sequence of the mouse immunoglobulin E gene: comparison with the human ε gene sequence. EMBO J. 1982. 1: 1117-1123.
47. Obata, M., Yamawaki-Kataoka, Y., Takahashi, N., Kataoka, T., Shimizu, A., Mano, Y., Seidman, J. G., Peterlin, M., Leder, P. and Honjo, T., Immunoglobulin γ-1 heavy chain gene: structural gene sequences cloned in a bacterial plasmid. Gene 1980. 9: 87-97.
48. Sikorav, J. L., Auffray, C. and Rougeon, F., Structure of the constant and 3′ untranslated regions of the murine BALB/c γ-2α heavy chain. Nucleic Acids Res. 1980. 8: 3143-3155.
49. Kondo, H., Ichikawa, Y., Nakamura, K. and Tsuchiya, S., Cloning of cDNA for new subtypes of murine low-affinity Fc receptor for IgE (FcεRII/CD23). Int. Arch. Allergy Immunol. 1994. 105: 38-48.